A Study of LY4268989 (MORF-057) in Healthy Participants

NCT06964776 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

144

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: LY4268989
DRUG: Placebo
DRUG: Midazolam
DRUG: Midazolam

Sponsor

Eli Lilly and Company